155 related articles for article (PubMed ID: 38302893)
1. Sociodemographic characteristics and their association with survival in women with cervical cancer.
Cetina-Pérez L; Luvián-Morales J; Delgadillo-González M; Castro-Eguiluz D; Galicia-Carmona T; Rely K; Vaca González R; Lugo-Martínez G; García-Barrientos N; Nateras A
BMC Cancer; 2024 Feb; 24(1):161. PubMed ID: 38302893
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
3. Morbidity of breast cancer and cervico-uterine cancer in women from the occidental region of Mexico.
Ortega-Cervantes L; Rojas-García AE; Robledo-Marenco Mde L; Barrón-Vivanco BS; Girón-Pérez MI; Vallejo-Ruiz V; López-Flores JF; Carrillo-Cortez A; Cantú-De León D; Rodríguez-Trejo A; Medina-Díaz IM
Rev Invest Clin; 2013; 65(3):221-7. PubMed ID: 23877809
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract][Full Text] [Related]
5. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.
Compaoré ZC; Monnet E; Gérazime A; Molinié F; Guizard AV; Delafosse P; Dabakuyo-Yonli TS; Coureau G; Hammas K; Plouvier S; Bara S; Défossez G; Lapôtre-Ledoux B; Daubisse-Marliac L; d'Almeida T; Launoy G; Mansi L; Trétarre B; Woronoff AS
Cancer Causes Control; 2022 Mar; 33(3):403-415. PubMed ID: 35079925
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico.
Palacio-Mejía LS; Rangel-Gómez G; Hernández-Avila M; Lazcano-Ponce E
Salud Publica Mex; 2003; 45 Suppl 3():S315-25. PubMed ID: 14746024
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009.
Park MJ; Park EC; Choi KS; Jun JK; Lee HY
BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening coverage and its related knowledge in southern Malawi.
Gerstl S; Lee L; Nesbitt RC; Mambula C; Sugianto H; Phiri T; Kachingwe J; Llosa AE
BMC Public Health; 2022 Feb; 22(1):295. PubMed ID: 35164716
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
Šavrova A; Jaal J; Nõmm O; Innos K
Public Health; 2023 Dec; 225():369-375. PubMed ID: 37989009
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
[TBL] [Abstract][Full Text] [Related]
11. Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.
Nõmm O; Veerus P; Orumaa M; Innos K
Cancer Epidemiol; 2022 Oct; 80():102231. PubMed ID: 35901623
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico.
Isla-Ortiz D; Palomares-Castillo E; Mille-Loera JE; Ramírez-Calderón N; Mohar-Betancourt A; Meneses-García AA; Reynoso-Noverón N
Oncologist; 2020 Sep; 25(9):e1363-e1371. PubMed ID: 32390238
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Level of Knowledge and Experience Regarding Cervical Cancer Prevention and Screening among Roma Women in Romania.
Voidăzan S; Budianu AM; Francisc RF; Kovacs Z; Uzun CC; Apostol BE; Bodea R
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893602
[No Abstract] [Full Text] [Related]
15. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
16. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
Keetile M; Ndlovu K; Letamo G; Disang M; Yaya S; Navaneetham K
PLoS One; 2021; 16(8):e0255581. PubMed ID: 34347841
[TBL] [Abstract][Full Text] [Related]
18. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
[TBL] [Abstract][Full Text] [Related]
19. The role of socio-demographic factors in premature cervical cancer mortality in Colombia.
Bermedo-Carrasco S; Waldner CL
BMC Public Health; 2016 Sep; 16():981. PubMed ID: 27628314
[TBL] [Abstract][Full Text] [Related]
20. Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.
Barquet-Muñoz SA; Cruz-Rodríguez E; Cantú De León DF; Isla-Ortiz D; Montalvo-Esquivel G; Herrera-Montalvo LA; Pérez-Plasencia C; Pérez-Montiel D; Herrera-Gómez Á
Rev Invest Clin; 2017; 69(5):286-292. PubMed ID: 29077701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
